Mass. Dx firm raises funds to further develop autism test

03/28/2013 | American City Business Journals

SynapDx has received an undisclosed investment from the Kraft Group, the third round of financing for the firm since December. The Massachusetts-based company will use the money to advance the development of its blood-based test for the early detection of autism spectrum disorder in children.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ